- Home
- SBFG vs LRMR Comparison
SBFG vs LRMR Comparison
Compare SBFG & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- LRMR
- Stock Information
- Founded
- SBFG 1983
- LRMR N/A
- Country
- SBFG United States
- LRMR United States
- Employees
- SBFG N/A
- LRMR N/A
- Industry
- SBFG Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- SBFG Finance
- LRMR Health Care
- Exchange
- SBFG Nasdaq
- LRMR Nasdaq
- Market Cap
- SBFG 155.9M
- LRMR 183.8M
- IPO Year
- SBFG N/A
- LRMR N/A
- Fundamental
- Price
- SBFG $21.15
- LRMR $2.35
- Analyst Decision
- SBFG
- LRMR Strong Buy
- Analyst Count
- SBFG 0
- LRMR 10
- Target Price
- SBFG N/A
- LRMR $19.60
- AVG Volume (30 Days)
- SBFG 18.7K
- LRMR 903.2K
- Earning Date
- SBFG 04-17-2025
- LRMR 03-24-2025
- Dividend Yield
- SBFG 2.74%
- LRMR N/A
- EPS Growth
- SBFG N/A
- LRMR N/A
- EPS
- SBFG 1.72
- LRMR N/A
- Revenue
- SBFG $56,774,000.00
- LRMR N/A
- Revenue This Year
- SBFG N/A
- LRMR N/A
- Revenue Next Year
- SBFG N/A
- LRMR N/A
- P/E Ratio
- SBFG $12.32
- LRMR N/A
- Revenue Growth
- SBFG 0.08
- LRMR N/A
- 52 Week Low
- SBFG $13.01
- LRMR $2.19
- 52 Week High
- SBFG $24.48
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- SBFG 54.16
- LRMR 37.36
- Support Level
- SBFG $20.14
- LRMR $2.19
- Resistance Level
- SBFG $21.98
- LRMR $2.44
- Average True Range (ATR)
- SBFG 0.64
- LRMR 0.19
- MACD
- SBFG 0.22
- LRMR 0.00
- Stochastic Oscillator
- SBFG 76.42
- LRMR 21.05
About SBFG SB Financial Group Inc.
SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.